Culture of Purified Stem Cells from Fetal Liver Results in Loss of In Vivo Repopulating Potential
- 1 February 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 5 (1) , 25-37
- https://doi.org/10.1089/scd.1.1996.5.25
Abstract
The development of in vitro conditions that promote a numerical expansion of hematopoietic stem cells (HSCs) with long-term reconstituting ability has been a long-standing goal in experimental hematology. In previous studies, we showed that input numbers of such cells, i.e., competitive repopulating units (CRU), could be maintained for 2 weeks when purified Sca-1+Lin−WGA+ adult bone marrow (BM) cells were cultured in serum-free and stromal cell-free cultures containing Steel factor (SF), interleukin 6 (IL-6), and erythropoietin (Epo). In separate studies, we showed that limiting numbers of purified fetal liver (FL) cells that are highly enriched for CRU display a higher proliferative and self-renewal potential in vivo compared with similar cells purified from adult BM. These findings prompted us to explore the possibility of achieving a numerical expansion of purified FL cells in culture. Although we observed an extensive increase in the number of nucleated FL cells in all culture conditions tested, none of the cultures, including cultures in serum-containing medium and cocultures on a preestablished feeder layer of BM stromal cells of S17 cells, sustained the expected expansion or even supported the maintenance of input numbers of FL CRU. Single cell cultures showed that the production of nucleated cells by purified Sca-1++Lin·−AA4.1+ FL cells stayed behind that of purified Sca-1+Lin−WGA+ adult BM cells. Taken together, our results show that a variety of culture conditions tested, including conditions that support maintenance and limited expansion of adult BM CRU do not support the production of repopulating stem cells from FL. Because such expansion can be observed in vivo, this system appears useful to search for novel culture conditions and—perhaps yet unidentified—cytokines or other microenvironment-related factors that may be required for FL CRU to prevent loss of repopulation potential in vitro and allow these cells to exhibit their expected self-renewal potential.Keywords
This publication has 33 references indexed in Scilit:
- The ins and outs of fibroblast growth factorsCell, 1994
- Role of insulin-like growth factors in embryonic and postnatal growthCell, 1993
- RETRACTED ARTICLE: Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cellsNature, 1992
- Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.The Journal of Experimental Medicine, 1992
- Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo.The Journal of Experimental Medicine, 1991
- Graft-Versus-Host DiseaseAnnual Review of Medicine, 1991
- Identification and characterization of an inhibitor of haemopoietic stem cell proliferationNature, 1990
- Insulin-like Growth Factors Promote DNA Synthesis and Support Cell Viability in Fetal Hemopoietic Tissue by Paracrine MechanismsGrowth Factors, 1990
- Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cellsNature, 1988
- Competitive in vivo proliferation of foetal and adult haematopoietic cells in lethally irradiated miceJournal of Cellular Physiology, 1972